Sukumar Nagendran
President and Head of R&D at Taysha Gene Therapies · 15 reported transactions in 1 company · latest trade Jul 10, 2026
Their trades
Sold | Jul 10, 2026 | Jul 10, 2026 close $6.34 → Oct 23, 2026 close $3.96. S&P 500 +0.7% over the same days. | ||
Sold | Jan 26, 2026 | Jan 26, 2026 close $4.72 → Oct 23, 2026 close $3.96. S&P 500 +9.7% over the same days. | ||
Sold | Jan 23, 2026 | Jan 23, 2026 close $4.66 → Oct 23, 2026 close $3.96. S&P 500 +10.3% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $4.86 → Oct 23, 2026 close $3.96. S&P 500 +9.3% over the same days. | ||
Sold | Dec 1, 2025 | Dec 1, 2025 close $4.43 → Oct 23, 2026 close $3.96. S&P 500 +11.7% over the same days. | ||
Sold | Nov 28, 2025 | Nov 28, 2025 close $4.74 → Oct 23, 2026 close $3.96. S&P 500 +11.2% over the same days. |
$1.25M
Jul 10, 2026 close $6.34 → Oct 23, 2026 close $3.96. S&P 500 +0.7% over the same days.
$124.1K
Jan 26, 2026 close $4.72 → Oct 23, 2026 close $3.96. S&P 500 +9.7% over the same days.
$423.4K
Jan 23, 2026 close $4.66 → Oct 23, 2026 close $3.96. S&P 500 +10.3% over the same days.
$942K
Jan 12, 2026 close $4.86 → Oct 23, 2026 close $3.96. S&P 500 +9.3% over the same days.
$1.17M
Dec 1, 2025 close $4.43 → Oct 23, 2026 close $3.96. S&P 500 +11.7% over the same days.
$523.1K
Nov 28, 2025 close $4.74 → Oct 23, 2026 close $3.96. S&P 500 +11.2% over the same days.